Logo image of RKLB

ROCKET LAB CORP (RKLB) Stock Fundamental Analysis

USA - NASDAQ:RKLB - US7731211089 - Common Stock

64.26 USD
-2.16 (-3.25%)
Last: 10/10/2025, 8:55:40 PM
63.35 USD
-0.91 (-1.42%)
After Hours: 10/10/2025, 8:55:40 PM
Fundamental Rating

3

RKLB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 69 industry peers in the Aerospace & Defense industry. While RKLB seems to be doing ok healthwise, there are quite some concerns on its profitability. RKLB is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RKLB had negative earnings in the past year.
RKLB had a negative operating cash flow in the past year.
RKLB had negative earnings in each of the past 5 years.
RKLB had a negative operating cash flow in each of the past 5 years.
RKLB Yearly Net Income VS EBIT VS OCF VS FCFRKLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

RKLB has a worse Return On Assets (-14.89%) than 73.53% of its industry peers.
The Return On Equity of RKLB (-33.60%) is worse than 72.06% of its industry peers.
Industry RankSector Rank
ROA -14.89%
ROE -33.6%
ROIC N/A
ROA(3y)-16.4%
ROA(5y)-18.08%
ROE(3y)-34.28%
ROE(5y)-34.08%
ROIC(3y)N/A
ROIC(5y)N/A
RKLB Yearly ROA, ROE, ROICRKLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

Looking at the Gross Margin, with a value of 29.04%, RKLB is in the better half of the industry, outperforming 66.18% of the companies in the same industry.
RKLB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RKLB Yearly Profit, Operating, Gross MarginsRKLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

5

2. Health

2.1 Basic Checks

RKLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RKLB has been increased compared to 1 year ago.
Compared to 5 years ago, RKLB has more shares outstanding
The debt/assets ratio for RKLB is higher compared to a year ago.
RKLB Yearly Shares OutstandingRKLB Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
RKLB Yearly Total Debt VS Total AssetsRKLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

RKLB has an Altman-Z score of 21.07. This indicates that RKLB is financially healthy and has little risk of bankruptcy at the moment.
RKLB has a better Altman-Z score (21.07) than 95.59% of its industry peers.
A Debt/Equity ratio of 0.60 indicates that RKLB is somewhat dependend on debt financing.
RKLB has a Debt to Equity ratio of 0.60. This is comparable to the rest of the industry: RKLB outperforms 42.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Altman-Z 21.07
ROIC/WACCN/A
WACC9.67%
RKLB Yearly LT Debt VS Equity VS FCFRKLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.67 indicates that RKLB has no problem at all paying its short term obligations.
RKLB has a Current ratio (2.67) which is comparable to the rest of the industry.
RKLB has a Quick Ratio of 2.33. This indicates that RKLB is financially healthy and has no problem in meeting its short term obligations.
RKLB has a better Quick ratio (2.33) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 2.33
RKLB Yearly Current Assets VS Current LiabilitesRKLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

7

3. Growth

3.1 Past

RKLB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.57%.
Looking at the last year, RKLB shows a very strong growth in Revenue. The Revenue has grown by 54.37%.
The Revenue has been growing by 55.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-28.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-62.5%
Revenue 1Y (TTM)54.37%
Revenue growth 3Y91.41%
Revenue growth 5Y55.23%
Sales Q2Q%36%

3.2 Future

Based on estimates for the next years, RKLB will show a very strong growth in Earnings Per Share. The EPS will grow by 32.40% on average per year.
RKLB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 32.13% yearly.
EPS Next Y-19.61%
EPS Next 2Y25.91%
EPS Next 3Y30.19%
EPS Next 5Y32.4%
Revenue Next Year35.16%
Revenue Next 2Y43.84%
Revenue Next 3Y39.67%
Revenue Next 5Y32.13%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RKLB Yearly Revenue VS EstimatesRKLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
RKLB Yearly EPS VS EstimatesRKLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RKLB. In the last year negative earnings were reported.
Also next year RKLB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RKLB Price Earnings VS Forward Price EarningsRKLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RKLB Per share dataRKLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as RKLB's earnings are expected to grow with 30.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.91%
EPS Next 3Y30.19%

More info and screens

0

5. Dividend

5.1 Amount

RKLB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROCKET LAB CORP

NASDAQ:RKLB (10/10/2025, 8:55:40 PM)

After market: 63.35 -0.91 (-1.42%)

64.26

-2.16 (-3.25%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners61.26%
Inst Owner Change0.14%
Ins Owners0.64%
Ins Owner Change9.26%
Market Cap31.10B
Analysts79.05
Price Target47.87 (-25.51%)
Short Float %12.73%
Short Ratio2.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.65%
Min EPS beat(2)-11.38%
Max EPS beat(2)8.09%
EPS beat(4)3
Avg EPS beat(4)3.2%
Min EPS beat(4)-11.38%
Max EPS beat(4)12.21%
EPS beat(8)7
Avg EPS beat(8)8.2%
EPS beat(12)8
Avg EPS beat(12)4.25%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.82%
Min Revenue beat(2)-0.99%
Max Revenue beat(2)4.63%
Revenue beat(4)2
Avg Revenue beat(4)0.87%
Min Revenue beat(4)-0.99%
Max Revenue beat(4)4.63%
Revenue beat(8)2
Avg Revenue beat(8)-1.29%
Revenue beat(12)5
Avg Revenue beat(12)-0.34%
Revenue beat(16)8
Avg Revenue beat(16)1.42%
PT rev (1m)2.67%
PT rev (3m)65.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.79%
EPS NY rev (1m)-2.57%
EPS NY rev (3m)-8.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.62%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)2.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 61.67
P/FCF N/A
P/OCF N/A
P/B 45.17
P/tB 55.19
EV/EBITDA N/A
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS1.04
BVpS1.42
TBVpS1.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.89%
ROE -33.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.04%
FCFM N/A
ROA(3y)-16.4%
ROA(5y)-18.08%
ROE(3y)-34.28%
ROE(5y)-34.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 268.86%
Cap/Sales 18.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.67
Quick Ratio 2.33
Altman-Z 21.07
F-Score4
WACC9.67%
ROIC/WACCN/A
Cap/Depr(3y)174.96%
Cap/Depr(5y)206.2%
Cap/Sales(3y)19.28%
Cap/Sales(5y)34.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-62.5%
EPS Next Y-19.61%
EPS Next 2Y25.91%
EPS Next 3Y30.19%
EPS Next 5Y32.4%
Revenue 1Y (TTM)54.37%
Revenue growth 3Y91.41%
Revenue growth 5Y55.23%
Sales Q2Q%36%
Revenue Next Year35.16%
Revenue Next 2Y43.84%
Revenue Next 3Y39.67%
Revenue Next 5Y32.13%
EBIT growth 1Y-28.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year51.27%
EBIT Next 3Y41.55%
EBIT Next 5Y31.86%
FCF growth 1Y-70.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50.93%
OCF growth 3YN/A
OCF growth 5YN/A